Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 10
Submit an article Journal homepage
303
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia*

Harold Bays Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USACorrespondence[email protected]
,
Aditi Sapre Merck & Co., INC., Rahway, NJ, USA
,
William Taggart Merck & Co., INC., Rahway, NJ, USA
,
Ji Liu Merck & Co., INC., Rahway, NJ, USA
,
Rachel Capece Merck & Co., INC., Rahway, NJ, USA
&
Andrew Tershakovec Merck & Co., INC., Rahway, NJ, USA
Pages 2953-2966 | Accepted 24 Jul 2008, Published online: 08 Sep 2008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.